BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27416841)

  • 1. Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis.
    Abuelezam NN; McCormick AW; Fussell T; Afriyie AN; Wood R; DeGruttola V; Freedberg KA; Lipsitch M; Seage GR
    Am J Epidemiol; 2016 Aug; 184(3):239-48. PubMed ID: 27416841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
    Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
    Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community.
    Alsallaq RA; Baeten JM; Celum CL; Hughes JP; Abu-Raddad LJ; Barnabas RV; Hallett TB
    PLoS One; 2013; 8(1):e54575. PubMed ID: 23372738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for HIV control in South Africa: a model-based analysis.
    Johnson LF; Chiu C; Myer L; Davies MA; Dorrington RE; Bekker LG; Boulle A; Meyer-Rath G
    Glob Health Action; 2016; 9():30314. PubMed ID: 27282146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
    Havlir D; Lockman S; Ayles H; Larmarange J; Chamie G; Gaolathe T; Iwuji C; Fidler S; Kamya M; Floyd S; Moore J; Hayes R; Petersen M; Dabis F;
    J Int AIDS Soc; 2020 Feb; 23(2):e25455. PubMed ID: 32091179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.
    Long EF; Stavert RR
    J Gen Intern Med; 2013 Oct; 28(10):1294-301. PubMed ID: 23588668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaling up circumcision programs in Southern Africa: the potential impact of gender disparities and changes in condom use behaviors on heterosexual HIV transmission.
    Andersson KM; Owens DK; Paltiel AD
    AIDS Behav; 2011 Jul; 15(5):938-48. PubMed ID: 20924783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa.
    Eaton JW; Johnson LF; Salomon JA; Bärnighausen T; Bendavid E; Bershteyn A; Bloom DE; Cambiano V; Fraser C; Hontelez JA; Humair S; Klein DJ; Long EF; Phillips AN; Pretorius C; Stover J; Wenger EA; Williams BG; Hallett TB
    PLoS Med; 2012; 9(7):e1001245. PubMed ID: 22802730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d'Ivoire: Insights from mathematical modeling.
    Maheu-Giroux M; Vesga JF; Diabaté S; Alary M; Baral S; Diouf D; Abo K; Boily MC
    PLoS Med; 2017 Jun; 14(6):e1002321. PubMed ID: 28617810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision.
    Mudimu E; Peebles K; Mukandavire Z; Nightingale E; Sharma M; Medley GF; Klein DJ; Kripke K; Bershteyn A
    PLoS One; 2020; 15(12):e0244761. PubMed ID: 33382803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the impact on HIV incidence of combination prevention strategies among men who have sex with men in Beijing, China.
    Lou J; Blevins M; Ruan Y; Vermund SH; Tang S; Webb GF; Shepherd BE; He X; Lu H; Shao Y; Qian HZ
    PLoS One; 2014; 9(3):e90985. PubMed ID: 24626165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 90-90-90 on HIV-1 incidence and mortality in eSwatini: a mathematical modelling study.
    Akullian A; Morrison M; Garnett GP; Mnisi Z; Lukhele N; Bridenbecker D; Bershteyn A
    Lancet HIV; 2020 May; 7(5):e348-e358. PubMed ID: 32061317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
    Verguet S; Stalcup M; Walsh JA
    Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vital need to engage the community in HIV control in South Africa.
    Hanson S; Zembe Y; Ekström AM
    Glob Health Action; 2015; 8():27450. PubMed ID: 26257046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets.
    Kripke K; Reed J; Hankins C; Smiley G; Laube C; Njeuhmeli E
    PLoS One; 2016; 11(10):e0155734. PubMed ID: 27783681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: [corrected] The changing face of the HIV epidemic in sub-Saharan Africa.
    Mutevedzi PC; Newell ML
    Trop Med Int Health; 2014 Sep; 19(9):1015-28. PubMed ID: 24976370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To cut or not to cut: a modeling approach for assessing the role of male circumcision in HIV control.
    Podder CN; Sharomi O; Gumel AB; Moses S
    Bull Math Biol; 2007 Nov; 69(8):2447-66. PubMed ID: 17557187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa.
    Kharsany ABM; Cawood C; Lewis L; Yende-Zuma N; Khanyile D; Puren A; Madurai S; Baxter C; George G; Govender K; Beckett S; Samsunder N; Toledo C; Ayalew KA; Diallo K; Glenshaw M; Herman-Roloff A; Wilkinson E; de Oliveira T; Abdool Karim SS; Abdool Karim Q
    JAMA Netw Open; 2019 Nov; 2(11):e1914378. PubMed ID: 31675082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of sexual risk behaviours and HIV seroprevalence among circumcised and uncircumcised men before and after implementation of the safe male circumcision programme in Uganda.
    Kibira SP; Sandøy IF; Daniel M; Atuyambe LM; Makumbi FE
    BMC Public Health; 2016 Jan; 16():7. PubMed ID: 26727935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study.
    Williams BG; Gupta S; Wollmers M; Granich R
    Lancet Public Health; 2017 May; 2(5):e223-e230. PubMed ID: 29253488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.